SLP News and Press, Simulations Plus Inc. From 06/03/24

2024-06-03 01:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-30 09:30:03 ET BTIG analyst issues BUY recommendation for SLP on May 30, 2024 07:21AM ET. The previous analyst recommendation was Buy. SLP was trading at $48.54 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recom...

2024-05-26 12:20:00 ET Summary Conestoga Capital Advisors LLC is a boutique, independent investment advisory firm specializing in the management of Micro, Small, SMid and Mid Cap Growth equities. Conestoga Capital Advisors utilizes a fundamental, bottom-up research process and employs...

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that Shawn O’Connor, chief executive officer, will participate i...

Redesigned platform offers ease-of-use, enhanced software engineering, and significant productivity gains for users Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods in...

2024-05-14 03:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-14 01:16:45 ET Summary Simulations Plus is benefiting from the growing use of computational tools in drug discovery, which would be boosted by the FDA Modernization Act 2.0. The biosimulation market is highly fragmented and underpenetrated, providing SLP with both organic ...

2024-05-04 09:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-04 12:19:09 ET More on Simulations Plus Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI ...

Simulations Plus, Inc. (NASDAQ: SLP) is one of today's top gainers. The company's shares have moved 22.75% on the day to $47.21. Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial inte...